Volume 24, Number 11—November 2018
Dispatch
Detection and Characterization of Human Pegivirus 2, Vietnam
Table 1
Infection | No. persons | Screening approach | No. positive for HPgV-2 | Enrollment period | Setting |
---|---|---|---|---|---|
Hepatitis C virus and HIV co-infection |
79 |
HPgV-2–specific PCR and reference-based mapping of obtained viral metagenomics data |
5 |
2010–2013 |
Hospital for Tropical Diseases,
Ho Chi Minh City |
HIV monoinfection |
78 |
HPgV-2–specific PCR |
0 |
2010–2013 |
Hospital for Tropical Diseases,
Ho Chi Minh City |
None (healthy volunteers) |
80 |
HPgV-2–specific PCR |
0 |
2010–2013 |
Hospital for Tropical Diseases,
Ho Chi Minh City |
Hepatitis A virus |
71 |
HPgV-2–specific PCR |
0 |
2012–2014 |
Hospital for Tropical Diseases,
Ho Chi Minh City |
Hepatitis B virus |
103 |
HPgV-2–specific PCR |
0 |
2012–2016 |
Hospital for Tropical Diseases,
Ho Chi Minh City; Dong Thap General Hospital, Dong Thap; Khanh Hoa Provincial Hospital, Nha Trang; Dac Lac Provincial Hospital, Dac Lac; Hue National Hospital, Hue |
Hepatitis C virus† | 394 | Reference-based mapping of obtained viral metagenomics data | 0 | 2012–2016 | Hospital for Tropical Diseases, Ho Chi Minh City; Dong Thap General Hospital, Dong Thap; Khanh Hoa Provincial Hospital, Nha Trang; Dac Lac Provincial Hospital, Dac Lac; Hue National Hospital, Hue |
*HPgV-2, human pegivirus.
†Whole-genome sequences of hepatitis C virus were obtained using a viral metagenomics approach (7). The resulting metagenomics datasets were then subjected to a reference-based mapping approach to search for the presence of HPgV-2 sequences.
1Members of the Southeast Asia Infectious Disease Clinical Research Network are listed at the end of this article.
Page created: October 17, 2018
Page updated: October 17, 2018
Page reviewed: October 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.